Vitiligo after hematopoietic cell transplantation: Six cases and review of the literature

Dermatology

Volumn 216, Issue 4, 2008, Pages 349-354

  Sanli, Hatice ^a   Akay, Bengü Nisa ^a   Arat, Mutlu ^a   Koçyigit, Pelin ^a   Akan, Hamdi ^a   Beksac, Meral ^a   Ilhan, Osman ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Vitiligo

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; METHYLPREDNISOLONE; STEROID;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALOPECIA AREATA; ANAMNESIS; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG WITHDRAWAL; DRY EYE; ERYTHEMA; FEMALE; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ICHTHYOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PUVA; SIDE EFFECT; SKINFOLD THICKNESS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; VITILIGO; XEROSTOMIA;

ADULT; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PREVALENCE; VITILIGO;

EID: 43049126520     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000117705     Document Type: Article

References (35)

1. Kemp EH, Waterman EA, Weetman AP: Autoimmune aspects of vitiligo. Autoimmunity 2001;34:65-77.
2. Hegedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M: High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994;74:120-123.
3. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA: Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res 2003;16:208-214.
4. Sharma VK, Dawn G, Kumar B: Profile of alopecia areata in Northern India. Int J Dermatol 1996;35:22-27.
5. Nagler A, Goldenhersh MA, Levi-Schaffer F, Bystryn JC, Klaus SN: Total leucoderma: a rare manifestation of cutaneous chronic graft-versus-host disease. Br J Dermatol 1996;134:780-783.
6. Aubin F, Cahn JY, Ferrand C, Angonin R, Humbert P, Tiberghien P: Extensive vitiligo after ganciclovir treatment of GVHD in a patient who had received donor T cells expressing herpes simplex virus thymidine kinase. Lancet 2000;355:626-627.
7. Neumeister P, Strunk D, Apfelbeck U, Sill H, Linkesch W: Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma. Lancet 2000;355:1334-1335.
8. Au WY, Yeung CK, Chan HH, Lie AK: Generalized vitiligo after lymphocyte infusion for relapsed leukemia. Br J Dermatol 2001;145:1015-1017.
9. Alajlan A, Alfadley A, Pedersen KT: Transfer of vitiligo after allogeneic bone marrow transplantation. J Am Acad Dermatol 2002;46:606-610.
10. Cho SB, Roh MR, Chung KY, Lee KH, Park YK: Generalized vitiligo after allogeneic bone marrow transplantation. Acta Derm Venereol 2005;85:82-83.
11. Cathcart S, Marrell D: Vitiligo as a post-bone marrow transplantation complication. J Pediatr Hematol Oncol 2007;29:485-487.
12. Sherer Y, Shoenfeld Y: Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 1998;22:873-881.
13. Johnson ML, Farmer ER: Graft-versus-host reactions in dermatology. J Am Acad Dermatol 1998;38:369-392.
14. Kawakami Y, Robbins PF, Wang RF, Parkhurst M, Kang X: The use of melanosomal proteins in the immunotherapy of melanoma. J Immunother Emphasis Tumour Immunol 1998;21:237-256.
15. Rouquette Gally AM, Boyeldieu D, Prost AC, Gluckman E: Autoimmunity after allogeneic bone marrow transplantation: a study of 53 long-term-surviving patients. Transplantation 1988;46:238-240.
16. Ferrara JLM, Deeg HJ: Graft-versus-host disease. N Engl J Med 1991;324:667-674.
17. Krasagakis K, Garbe C, Zouboulis CC, Orfanos CE: Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res 1995;139:169-182.
18. Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M, Fabbri P: New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res 2002;15:87-92.
19. Rigopoulos D, Gregoriou S, Larios G, Moustou E, Belayeva-Karatza E, Kalogeromitros D: Etanercept in the treatment of vitiligo. Dermatology 2007;215:84-85.
20. Seirafi H, Farnaghi F, Firooz A, Vasheghani-Farahani A, Alirezaie NS, Dowlati Y: Pimecrolimus cream in repigmentation of vitiligo. Dermatology 2007;214:253-259.
21. Göktay F, Mansur AT, Aydingöz IE: Colocalization of vitiligo and lichen planus on scrotal skin: a finding contrary to the actinic damage theory. Dermatology 2006;212:390-392.
22. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG: Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001;98:1594-1600.
23. Imamura M, Hashino S, Kobayashi H, Kubayashi S, Hirano S, Minagawa T, Tanaka J, Fujii Y, Kobayashi M, Kasai M, et al: Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease. Bone Marrow Transplant 1994;13:745-751.
24. Taştan B, Akar A, Orkunoǧlu E, Arca E, İnal A: Association of HLA class 1 antigens and HLA class 2 alleles with vitiligo in a Turkish Population. Pigment Cell Res 2004;17:181-184.
25. Wyatt DT, Lum LG, Casper J, Hunter J, Camitta B: Autoimmune thyroiditis after bone marrow transplantation. Bone Marrow Transplant 1990;5:357-361.
26. Gardembas-Pain M, Ifrah N, Foussard C, Boasson M, Andre JPS, Verret JL: Psoriasis after allogeneic bone marrow transplantation (letter). Arch Dermatol 1990;126:1523.
27. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H: Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993;341:1243-1244.
28. Waters AH, Metcalfe P, Minchinton RM, Barrett AJ, James DC: Autoimmune thrombocytopenia acquired from allogeneic bone marrow graft: compensated thrombocytopenia in bone marrow donor and recipient (letter). Lancet 1983;2:1430.
29. Remberger M, Kumlien G, Aschan J, Barkholt L, Hentschke P, Ljungman P, et al: Risk factors for moderate-to-severe chronic graft versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002;8:674-682.
30. Fishman P, Merimski O, Baharav E, Shoenfeld Y: Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo. Cancer 1997;79:1461-1464.
31. Bouloc A, Grange F, Delfau-Larue MH, Dieng MT, Tortel MC, Avril MF, Revuz J, Bagot M, Wechsler J: Leucoderma associated with flares of erythrodermic cutaneous Tcell lymphomas: four cases. The French Study Group of Cutaneous Lymphomas. Br J Dermatol 2000;143:832-836.
32. Fisher AA: Ask the experts: the differential diagnosis of contact leukoderma. Am J Contact Dermat 1997;8:52-55.
33. Kumar A, Freeman S: Leukoderma following occupational allergic contact dermatitis. Contact Dermatitis 1999;41:94-98.
34. Mimouni D, David M, Feinmesser M, Coire CI, Hodak E: Vitiligo-like leucoderma during photochemotherapy for mycosis fungoides. Br J Dermatol 2001;145:1008-1014.
35. Musette P, Bachelez H, Flageul B, Delarbre C, Kourilsky P, Dubertret L, Gachelin G: Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cell clones. J Immunol 1999;162:1789-1794.